Literature DB >> 9804627

Enantioselective blockade of T-type Ca2+ current in adult rat sensory neurons by a steroid that lacks gamma-aminobutyric acid-modulatory activity.

S M Todorovic1, M Prakriya, Y M Nakashima, K R Nilsson, M Han, C F Zorumski, D F Covey, C J Lingle.   

Abstract

A number of steroids seem to have anesthetic effects resulting primarily from their ability to potentiate currents gated by gamma-aminobutyric acidA (GABAA) receptor activation. One such compound is (3alpha,5alpha, 17beta)-3-hydroxyandrostane-17-carbonitrile [(+)-ACN]. We were interested in whether carbonitrile substitution at other ring positions might result in other pharmacological consequences. Here we examine effects of (3beta,5alpha, 17beta)-17-hydroxyestrane-3-carbonitrile [(+)-ECN] on GABAA receptors and Ca2+ channels. In contrast to (+)-ACN, (+)-ECN does not potentiate GABAA-receptor activated currents, nor does it directly gate GABAA-receptor mediated currents. However, both steroids produce an enantioselective reduction of T-type current. (+)-ECN blocked T current with an IC50 value of 0.3 microM with a maximal block of 41%. (+)-ACN produced a partial block of T current (44% maximal block) with an IC50 value of 0.4 microM. Block of T current showed mild use- and voltage-dependence. The (-)-ECN enantiomer was about 33 times less potent than (+)-ECN, with an IC50 value of 10 microM and an amount of maximal block comparable to (+)-ECN. (+)-ECN was less effective at blocking high-voltage-activated Ca2+ current in DRG neurons (IC50 value of 9. 3 microM with maximal block of about 27%) and hippocampal neurons. (+)-ECN (10 microM) had minimal effects on voltage-gated sodium and potassium currents in rat chromaffin cells. The results identify a steroid with no effects on GABAA receptors that produces a partial inhibition of T-type Ca2+ current with reasonably high affinity and selectivity. Further study of steroid actions on T currents may lead to even more selective and potent agents.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9804627     DOI: 10.1124/mol.54.5.918

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  22 in total

Review 1.  Modulation and pharmacology of low voltage-activated ("T-Type") calcium channels.

Authors:  Anne Marie R Yunker
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

Review 2.  T-type voltage-gated calcium channels as targets for the development of novel pain therapies.

Authors:  Slobodan M Todorovic; Vesna Jevtovic-Todorovic
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

3.  T-type calcium channel antagonists suppress tremor in two mouse models of essential tremor.

Authors:  Adrian Handforth; Gregg E Homanics; Douglas F Covey; Kathiresan Krishnan; Jae Yeol Lee; Kenji Sakimura; Fredricka C Martin; Arnulfo Quesada
Journal:  Neuropharmacology       Date:  2010-06-12       Impact factor: 5.250

4.  TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent.

Authors:  Wonjoo Choe; Richard B Messinger; Emily Leach; Veit-Simon Eckle; Aleksandar Obradovic; Reza Salajegheh; Vesna Jevtovic-Todorovic; Slobodan M Todorovic
Journal:  Mol Pharmacol       Date:  2011-08-05       Impact factor: 4.436

Review 5.  Neuropathic pain: role for presynaptic T-type channels in nociceptive signaling.

Authors:  Slobodan M Todorovic; Vesna Jevtovic-Todorovic
Journal:  Pflugers Arch       Date:  2013-01-16       Impact factor: 3.657

6.  Inhibition of CaV3.2 T-type calcium channels in peripheral sensory neurons contributes to analgesic properties of epipregnanolone.

Authors:  Christine Ayoola; Sung Mi Hwang; Sung Jun Hong; Kirstin E Rose; Christopher Boyd; Neda Bozic; Ji-Yong Park; Hari Prasad Osuru; Michael R DiGruccio; Douglas F Covey; Vesna Jevtovic-Todorovic; Slobodan M Todorovic
Journal:  Psychopharmacology (Berl)       Date:  2014-05-07       Impact factor: 4.530

7.  Are neuroactive steroids promising therapeutic agents in the management of acute and chronic pain?

Authors:  Vesna Jevtovic-Todorovic; Douglas F Covey; Slobodan M Todorovic
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

8.  5α-reduced progestogens ameliorate mood-related behavioral pathology, neurotoxicity, and microgliosis associated with exposure to HIV-1 Tat.

Authors:  Jason J Paris; ShiPing Zou; Yun K Hahn; Pamela E Knapp; Kurt F Hauser
Journal:  Brain Behav Immun       Date:  2016-01-13       Impact factor: 7.217

Review 9.  ent-Steroids: novel tools for studies of signaling pathways.

Authors:  Douglas F Covey
Journal:  Steroids       Date:  2008-12-03       Impact factor: 2.668

10.  Selective T-type calcium channel blockade alleviates hyperalgesia in ob/ob mice.

Authors:  Janelle R Latham; Sriyani Pathirathna; Miljen M Jagodic; Won Joo Choe; Michaela E Levin; Michael T Nelson; Woo Yong Lee; Kathiresan Krishnan; Douglas F Covey; Slobodan M Todorovic; Vesna Jevtovic-Todorovic
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.